Medtronic announced the primary and secondary outcomes of the VenaSeal Spectrum Venous Leg Ulcer study. According to the ...

Rampart IC, a developer of radiation shielding for interventional suites, announced the acquisition of ClearShield, ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

HistoSonics, developer of the Edison histotripsy system, announced 12-month follow-up clinical data from its prospective #HOPE4LI ...

Cordis announced new data from the SUCCESS PTA and SELUTION SFA Japan peripheral studies evaluating the company’s Selution ...

Delcath Systems, Inc. announced that it has received clearance from the FDA to initiate patient enrollment of a phase 2 clinical ...

Rampart IC announced the completion of a $21.6 million Series B financing round. The Alabama-based medical technology company ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study ...

Medtronic announced the release of data from a subgroup analysis of an atherectomy systematic literature review (SLR) that is eva ...

CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...